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Abstract 
Periodontitis is an inflammatory condition that destroys the tooth-supporting tissues, 
as a result of local bacterial infection. Aggregatibacter actinomycetemcomitans is a 
Gram-negative facultative anaerobic species, highly associated with Aggressive 
Periodontitis. Periodontal inflammation is dominated by cytokines of the Interleukin 
(IL)-1 family. Prior to their secretion by macrophages, IL-1 cytokines are processed 
by intracellular protein complexes, known as “inflammasomes”, which can sense the 
bacterial challenge. The aim of this study was to investigate which inflammasomes 
are regulated in mononuclear cells in response to A. actinomycetemcomitans. The 
D7SS strain and its derivative leukotoxin and cytolethal distending toxin knock-out 
mutant strains were used to infect human mononuclear cells at a 1:10 cell: bacteria 
ratio, for 3 h. The expression of various inflammasome components in the cells was 
investigated by TaqMan quantitative real-time polymerase chain reaction (qPCR). 
The expressions of NOD-like receptor protein (NLRP)1, NLRP2 and Absent In 
Melanoma (AIM)2 inflammasome sensors, as well as their effector Caspase-1 were 
not affected. However, NLRP3 was up-regulated, while NLRP6 was down-regulated. 
This effect was not dependent on the leukotoxin or the cytolethal distending toxin, as 
demonstrated by the use of specific gene knock-out mutant strains. IL-1β and IL-18 
expressions were also up-regulated by the bacterial challenge. In conclusion, A. 
actinomycetemcomitans enhances NLRP3 and reduces NLRP6 inflammasome 
expression, irrespective of its major virulence factors, confirming the high pathogenic 
profile of this species, and providing further insights to the mechanisms of periodontal 
inflammation.  
Keywords: Aggregatibacter actinomycetemcomitans, inflammasome, NLRP3, 
NLRP6, mononuclear leukocytes, interleukin-1β, aggressive periodontitis. 
  
3 
3 
1. Introduction 
Periodontitis is the most common chronic infectious inflammatory disease in man, 
characterised by the inflammatory destruction of the tooth supporting (periodontal) 
tissues. If left untreated, periodontitis will eventually lead to tooth loss. The 
etiological factor of the disease is oral bacteria colonizing the tooth surfaces as 
polymicrobial biofilm communities [1]. Aggregatibacter actinomycetemcomitans is a 
facultatively anaerobic Gram-negative bacterium, which is present frequently and in 
high numbers in biofilms from sites with localized aggressive periodontitis [2, 3]. 
This variant of periodontitis affects adolescents and young adults and is characterised 
by an early onset and rapid progression [4]. High proportions of A. 
actinomycetemcomitans in biofilms are strongly correlated with loss of periodontal 
tissue attachment in the affected sites [5]. This species may also be associated with 
systemic diseases, as it has occasionally been isolated from non-oral infections, 
including endocarditis, bacteremia, pericarditis, septicemia, pneumonia [6], as well as 
atherosclerotic plaque [7]. The pathogenic capacities of A. actinomycetemcomitans 
are well underlined by its virulence factors, including two protein exotoxins, which 
are prevalent among Gram-negative species [8, 9]. These are namely the leukotoxin 
and the cytolethal distending toxin (Cdt), belonging to the repeats-in-toxin (RTX) and 
Cdt superfamilies, respectively. The Cdt causes growth arrest and eventually 
apoptosis to virtually all eukaryotic cells [10-13]. Leukotoxin, predominantly 
associated with the bacterial surface [14, 15], can selectively kill human leukocytes by 
triggering apoptosis or lysis [16-19]. The lysis of human monocytes / macrophages by 
leukotoxin is mediated by the activation of the cysteine proteinase Caspase-1, which 
is also associated with the secretion of bio-active IL-1β [17, 20, 21]. In addition, the 
strong association between presence of the highly leuokotoxic clone (JP2) of A. 
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actinomycetemcomitans and disease progression indicates an important pathogenic 
role of the leukotoxin [22]. 
Cytokines of the IL-1 family, including IL-1β and IL-18, are central to the 
inflammatory host response in periodontal diseases [23, 24], as levels of IL-1β are 
higher in gingival crevicular fluid [25] or gingival tissues [26], in periodontitis. 
Macrophages are key cells in the local immune responses towards infection, and their 
main functions involve phagocytosis, antigen presentation and production of IL-1β. In 
fact, macrophages are the main source of IL-1β in inflamed tissue [27]. This cytokine 
is produced as an inactive precursor (pro-IL-1β) that is subsequently activated by 
Caspase-1 before being secreted as biologically active IL-1β [28]. Bacterial products, 
such as the lipopolysaccharide (LPS), can increase the expression of pro-IL-1β in 
macrophages [29]. However, the activation of Caspase-1 that further induces the 
secretion of biologically active IL-1β requires auxiliary stimuli, known as pathogen-
associated or danger-associated molecular patterns (PAMPs and DAMPs). These are 
sensed by “inflammasomes”, which are intracellular pattern recognition receptors 
(PRRs) that form oligomeric molecular platforms [30]. Inflammasome oligomeres 
consist of the “sensor” (or “scaffold”) nucleotide-binding oligomerization domain-like 
receptor (NLR) proteins, the mediating “adaptor” apoptotic speck protein containing a 
C-terminal caspase recruitment domain (ASC), and the “effector” pro-Caspase-1. 
Recognition of PAMPs or DAMPs by inflammasomes triggers the cleavage of pro-
Caspase-1 into its active form, in turn activating IL-1β into its mature secreted form. 
The most well characterised is the NLRP3 inflammasome that is activated in 
response to cell stress signals [31], whole bacteria and viruses, or their virulence 
factors [32-35], and is likely to play a key role in inflammatory periodontal disease 
[26]. NLRP2 is less well studied, but it is considered to inhibit the NLRP3-ASC 
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interaction [36, 37]. NLRP1 does not require the mediation of ASC for the activation 
of Caspase-1 [38], it can also activate Caspase-5 [39], and can be activated by the 
anthrax lethal toxin, causing cell death [40]. NLRP6 is as a critical regulator of pro-
inflammatory signal transduction, particularly by activating NF-κB and Caspase-1 
[41]. Recent studies demonstrated that it is and important PRR for developmental 
control of intestinal colonization by bacteria [42], epithelial self-renewal [43] and 
prevention of inflammation-induced tumorgenesis in the gut [44] or colitis [45]. 
Hence, this inflammasome may convey anti-inflammatory signals by commensal 
bacteria, crucial for the homeostatic maintenance [46]. Absent In Melanoma (AIM)2 
is the only non-NLR inflammasome that senses a broad spectrum of cytosolic double-
stranded DNA from  bacteria, viruses, or even the host [47]. Similarly to NLRP3, the 
AIM2 inflammasome platform also consists of ASC and Caspase-1 [48]. 
The inflammasome responses to A. actinomycetemcomitans infection are not 
known. Taken the ability of leukotoxin to activate an abundant secretion of bio-active 
IL-1β, its is important to further examine the regulation of the up-stream molecules 
responsible for this activation by A. actinomycetemcomitans [49]. Therefore, the 
present in vitro study aims to investigate the effects of A. actinomycetemcomitans on 
the expression of various inflammasomes in human mononuclear leukocytes, and to 
evaluate the potential involvement of the leukotoxin and the Cdt. 
 
2. Materials and Methods 
2.1 Bacterial strains 
The A. actinomycetemcomitans strain D7S-smooth wild-type (D7SS WT), serotype a, 
with a complete leukotoxin promoter and Cdt operon was used in this study. To 
evaluate the relative role of leukotoxin and Cdt in the effects, derivative D7SS 
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leukotoxin and/or Cdt knock-out mutant strains were used. These mutant strains were 
were namely the D7SS ∆ltxA, the D7SS ∆cdtABC and the D7SS ∆ltxA/CdtABC, in 
which, respectively, the ltxA gene, the CdtABC operon, or both, had been deleted and 
replaced with a spectinomycin resistance cassette [50]. The determination of the 
leukotoxic activity and Cdt-related growth inhibitory activity of the strains were 
previously determined [11, 21]. The strains were cultivated on blood agar plates at 37 
°C in aerobic atmosphere containing 5% CO2. After 72 h incubation, the bacterial 
colonies were harvested with a sterile cotton swab and suspended in phosphate 
buffered saline (PBS), at pH 7.2. The concentration of bacteria in the suspensions 
were quantified by measuring the optical density (OD 600nm) and counting the 
colonies cultivated on blood agar plates [51]. 
 
2.2 Leukocyte preparations 
Human mononuclear leukocytes (MNLs) were isolated from an enriched leukocyte 
fraction (buffy coat) obtained from 450 ml venous blood of one donor, at Norrland’s 
University Hospital blood bank (Umeå, Sweden). Ethical clearance was obtained by 
the committee of Umeå University, Sweden. MNLs were isolated by isopycnic 
centrifugation in Lymphopreps (Nycomed AB, Lidingo, Sweden) as described 
previously [21]. The monocytic and lymphocytic content of the MNL fraction was 
defined by measuring the forward scatter (FSC) and side scatter (SSC) by FACS. 
Approximately 30% of the cells corresponded to monocytes, whereas 70% of the cells 
to lymphocytes (Figure 1). The fraction containing MNLs was collected, washed 3 
times with PBS at 250 g for 10 min to remove the platelets. The cell pellet was then 
re-suspended in RPMI-1640 containing 10% FBS and penicillin–streptomycin to 
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yield 5 x 106 cells/ml. One ml of suspension was distributed to 1 or 2 cm2 culture 
dishes (NUNC A/S) and cultured for 20 h at 37 °C in 5% CO2 to equilibrate the cells.  
 
2.3 Bacterial exposure 
The cell culture medium was replaced by 0.25 ml fresh medium per well, containing 
the A. actinomycetemcomitans D7SS bacterial strains described above at 
concentrations 1:10 cell: bacteria ratio, for 3 h at 37 °C in 5% CO2. The selection of 
this ratio was based on previous work in this experimental system, demonstrating that 
the cells are induced to produce IL-1β, without exhibiting significant cytotoxicity 
[21]. At the end of the incubation period cells and supernatants were separated by 
centrifuging at 250g at 20 °C for 5 min. The control group consisted of cells cultured 
in the absence of bacteria. 
 
2.4 Cell lysis 
Cell lysis was determined as the release of the cytosolic enzyme lactate 
dehydrogenase (LDH) into the culture media from damaged cells, and its activity was 
measured spectophotometrically as described previously [14, 52] and expressed as 
absorbance at 340 nm. Data are normalized to control cultures exposed to culture 
medium alone, in the absence of bacteria.  
 
2.5 Propidium Iodide staining of the cells 
These cells were further analyzed for early detection of apoptosis/necrosis. For this 
purpose, the isolated MNLs were incubated in culture medium for 3 h, at 37 °C in the 
presence of 10 A. actinomycetemcomitans bacteria/cell. MNLs in plain culture 
medium served as controls. Upon termination of the experiment, the cell cultures were 
  
8 
8 
placed on ice and Propidium Iodide (PI) was added according to the Vybrant® 
Apoptosis Assay Kit #4 protocol (Molecular Probes/Invitrogen Labeling and 
Detection). The cells were incubated further for 30 min, detached with a sterile cell 
scraper (Corning Incorporated), transferred to FACS tubes and analyzed by FACS as 
soon as possible using 488 nm excitation with fluorescence emission at 575 nm (e.g., 
FL3) (Calibur, Becton Dickinson Immunocytometry Systems). Dead cells were 
stained positive for PI and their proportion was calculated in a population of 10000 
cells in each sample. 
 
2.6 Quantification of secreted Interleukin-1β  
Upon challenge of the macrophages with the various A. actinomycetemcomitans 
strains as described above, the cell culture supernatants were collected after the cells 
were removed by centrifugation. The concentrations of secreted IL-1β were then 
measured in the cell-free culture supernatants by using a commercially available 
ELISA kit (R&D systems, Abingdon, UK) that recognizes only the active form of this 
cytokine. 
 
2.7 RNA extraction and cDNA synthesis 
After completion of the experiments and removal of the cell-culture supernatants by 
centrifugation, the cell pellets were washed twice in PBS before being lysed. Total 
RNA was extracted by using the RNeasy Mini Kit (QIAGEN), according to the 
manufacturer’s instructions. The concentration of total RNA was measured by a 
spectrophotometer. Total RNA (400 ng) was then reverse transcribed into cDNA by 
using the High-Capacity cDNA Reverese Transcription Kit (Applied Biosystems) in a 
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volume of 20 µl, according to the manufacturer’s protocol. The resulting cDNA was 
stored at -20°C, until further use. 
 
2.8 Quantitative real-time Polymerase Chain Reaction (qPCR) 
For gene expression analyses, qPCR was performed in an ABI Prism 7000 Sequence 
Detection System and software (Applied Biosystems). GAPDH and UBC were used 
as endogenous RNA control in the samples (house-keeping genes). For the 
amplification reactions, the TaqMan Gene Expression Master Mix and Gene 
Expression Assay kits from Applied Biosystems were used (assay IDs NLRP1: 
Hs00248187-m1 , NLRP2: Hs001546938-m1, NLRP3: Hs00918085-m1, NLRP6: 
Hs00373246-m1, ASC: Hs01547324-m1, Caspase-1: Hs00354836-m1, AIM2: 
Hs00915710-m1, IL-1β: Hs00174097-m1, IL-18: Hs01038787-m1, GAPDH: 
Hs99999905-m1, and ubiquitin C (UBC): Hs00824723-m1). The standard PCR 
conditions were 10 min at 95ºC, followed 40 cycles at 95ºC for 15 seconds and 60ºC 
for 1 min. The expression levels of the target transcripts in each sample were 
calculated by the comparative Ct method (2-∆Ct formula) after normalization to the 
average of the two housekeeping genes. 
 
2.9 Statistical analysis 
A one-way analysis of variance (ANOVA) was used to analyze the statistical 
significances of the results, using Bonferroni post-hoc test for comparisons between 
individual groups. The data were considered significant at P<0.05. 
 
3. Results 
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After 3 h of challenge, the effect of A. actinomycetemcomitans on MNL death by cell 
lysis was determined by measuring the extracellularely released LDH activity. The 
results indicate no significant differences between the control and the A. 
actinomycetemcomitans-challenged groups (Table 1), indicating a low cytotoxic 
effect of the strain and concentrations used, within the short period of challenge. A 
slight increase in nuclear PI staining (corresponding to apoptosis) of the cells was 
observed in the presence of Cdt-producing strains (i.e. D7SS wild-type and D7SS 
∆ltxA) but this proved to be only at a 5% range (Table 1). 
To investigate the effect of A. actinomycetemcomitans on inflammasome 
expression, the MNL cultures were challenged for 3 h with the wild-type or the 
respective mutants strains, at 1:10 cells:bacteria ratio. The gene expression levels of 
the various inflammasome components were thereafter measured by qPCR. It was 
found that, compared to the unchallenged control, the expressions of the 
inflammasome sensors NLRP1 (Figure 2A), NLRP 2 (Figure 2B), AIM2 (Figure 2C) 
were not affected by A. actinomycetemcomitants challenge, irrespective of the strain 
used. On the contrary the expression of the inflammatory sensors NLRP3 and NLRP6 
were affected by A. actinomycetemcomitans challenge. NLRP3 expression was 
significantly up-regulated by all A. actinomycetemcomitans strains used, between 3.4-
fold and 5.0-fold, compared to the control (Figure 2D). Nevertheless, NLRP6 
expression was significantly down-regulated by all strains used, by 50% - 60% 
(Figure 2E). Interestingly, no significant differences were observed among the four A. 
actinomycetemcomitans strains in their capacity to induce NLRP3 or reduce NLRP6 
expression. 
The expression of the adaptor molecule ASC, as well as the effector Caspase-1 
was also investigated (Figure 3). ASC was down-regulated by A. 
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actinomycetemcomitans challenge by 33% - 58% (Figure 3A), whereas the expression 
of Caspase-1 was not affected (Figure 3B). Again, there were no significant 
differences in the capacity of the different A. actinomycetemcomitans strains to down-
regulate ASC expression. 
Further on, the effect of A. actinomycetemcomitans on the transcription of IL-1 
family cytokines, namely IL-1β and IL-18, was investigated (Figure 4). There was a 
clear induction of IL-1β expression by A. actinomycetemcomitans by 17-fold to 21-
fold (Figure 4A). In the case of IL-18, a numerical enhancement of was observed, 
which however did not proved to be statistically significant, due to the high standard 
deviation between experiments (Figure 4B). 
The levels of IL-1β secretion by the MNLs in response to A. 
actinomycetemcomitans, were further investigated by ELISA (Table 2). It was found 
that A. actinomycetemcomitans challenge enhanced IL-1β secretion by the cells. 
However, no differences were observed between the wild-type and mutant strains in 
this capacity. 
 
4. Discussion 
This study demonstrated that A. actinomycetemcomitans induced NLRP3 and reduced 
NLRP6 inflammasome gene expression in human MNLs, whereas it did not affect the 
expressions of NLRP1, NLRP2 or AIM2. As NLRP3 is a sensor associated with 
PAMP or DAMP recognition [53], whereas NLRP6 is associated with homeostatic or 
“protective” molecular signals [46], the findings denote that A. 
actinomycetemcomitans is perceived by the macrophages as a pathogen. Interestingly, 
the expression of the adaptor molecule ASC, that mediates NLR binding to Caspase-
1, is down-regulated by A. actinomycetemcomitans infection. These results are in 
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agreement with the up-regulation of NLRP3 [26] and down-regulation of ASC [26, 
54] in myelomonocytic Monomac-6 or monocytic THP1 cells, by the major 
periodontal pathogen Porphyromonas gingivalis. Similar findings were are also 
demonstrated in another experimental system, in which Listeria monocytogenes is 
shown to up-regulate NLRP3, but down-regulate NLRP6 and ASC expression in 
human peripheral blood mononuclear cells [55]. In contrast, in gingival epithelial 
cells P. gingivalis down-regulates NLRP3 expression, but it does not affect ASC [56], 
denoting that inflammasome responses to a given species may as well be cell-type 
specific. Although it is difficult to assess the net functional effect of the differential 
regulation of NLRP3 and ASC, bacterial pathogens may strategically perturb the 
expression of various inflammasome components, in order to manipulate the innate 
immune responses [57]. To this extent, supragingival and subgingival biofilms were 
shown to differentially regulate the expression of the NLRP3 and AIM2 
inflammasomes in gingival fibroblasts, denoting the different pathogenic potential of 
these two biofilm variants for periodontal diseases [58].  
Inflammasomes regulate the activation of Caspase-1, which itself constitutes 
the effector molecule of these oligomeric platforms. The end-point outcome of 
Caspase-1 activation is IL-1 cytokine secretion. The effect of A. 
actinomycetemcomitans on the transcriptional expression of Caspase-1, as well as IL-
1β and IL-18 was also investigated in the present experimental system. Caspase-1 
expression in MNLs was not affected in response to any of the A. 
actinomycetemcomitans strains used, but IL-1β and IL-18 expressions were up-
regulated. In line with these findings, infection of macrophages with A. 
actinomycetemcomitans does not affect the intracellular levels of pro-Caspase-1 [20], 
although its leukotoxin can promote Caspase-1 activation [17] and enhanced IL-1β 
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production. In the absence of leukotoxin, transcribed pro-IL-1β is withheld 
intracellularly [20, 21].  
The present study also investigated the potential role of leukotoxin and Cdt, 
the two major virulence factors of A. actinomycetemcomitans, in the observed effects. 
It was found that neither toxin was involved in the differential regulations of 
inflammasome components, namely of NLRP3, NLRP6 and ASC. Hence, it appears 
that A. actinomycetemcomitans is sensed by inflammasomes irrespective of these two 
major virulence factors, albeit for the activation of the effector molecule Caspase-1 
and subsequent IL-1β secretion, leukotoxin is required [17, 20]. The relative effect of 
A. actinomycetemcomitans leukotoxin and Cdt on IL-1β and IL-18 expressions by the 
cells was also considered in this study. Of note, IL-18 was expressed at lower levels 
that IL-1β, also in line with recent findings in macrophages [59] and gingival 
fibroblasts [58]. Although none of the A. actinomycetemcomitans knock-out mutant 
strains differentially regulated IL-1β expression compared to the wild-type strain, they 
all appeared to enhance IL-18 expression levels by the cells, but this did not prove to 
be statistically significant, due to the large standard deviation between experiments. 
Moreover, leukotoxin was previously shown not to be able to cause a significant 
effect on IL-1β gene expression [59]. Therefore, the leukotoxin and Cdt at sub-lethal 
concentrations do not appear to be clearly involved in the A. actinomycetemcomitants-
induced IL-1β expression by MNLs. 
The potential effect of A. actinomycetemcomitans and its virulence factors on 
IL-1β secretion by the MNLs was also considered in the present experimental study. 
Although IL-1β secretion was enhanced, no differences were observed between the 
effects of the wild-type and knock-out mutant strains. The lack of additive effect on 
IL-1 β in the presence of leukotoxin may be surprising. However, it is likely to be due 
  
14 
14 
to the fact that the D7SS strain is a low leukotoxic strain [21], and therefore may not 
further enhance IL-1β at the low (1:10) concentrations used. Accordingly, no 
significant differences were observed in the cytotoxic effects of the different strains, 
as indicated by the LDH release and PI staining data, indicating further the lack of any 
pronounced effect by the leukotoxin. It can therefore be concluded that in the present 
experimental system, A. actinomycetemcomitans did not induce the “pyroptotic” cell 
death and associated IL-1β release attributed to the leukotoxin [21, 59]. This could 
either be attributed to the low leukotoxin-producing activity of the D7SS strain, or to 
the fact that a whole MNL population was used, rather than isolated more sensitive 
macrophages. The MNL mixture is dominated by cells of lymphoid origin, which are 
less sensitive to the leukotoxin and might compete with the sensitive monocytes in 
leukotoxin binding. 
 
5. Conclusion 
In conclusion, the present study indicates that A. actinomycetemcomitans enhances the 
expression of NLRP3 and reduces the expression of NLRP6 in MNLs, irrespective of 
its two major exotoxins. Given the PAMP-sensing role of the former inflammasome 
[53] and the commensal-sensing role of the latter [46], this dual regulation is 
commensurate with the high pathogenic profile of A. actinomycetemcomitans [8] in 
Aggressive Periodontitis.  
 
6. Acknowledgements 
The authors would like to thank Mrs Elpida Plattner for her excellent technical 
assistance and Dr. Casey Chen (University of Southern California, Los Angeles) for 
  
15 
15 
providing the A. actinomycetemcomitans D7SS strains. This study was supported by 
the authors’ Institutes. 
 
References 
[1] Marsh PD. Dental plaque: biological significance of a biofilm and community 
life-style. J Clin Periodontol 2005;32 Suppl 6: 7-15. 
[2] Slots J, Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas 
gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 
1999;20: 82-121. 
[3] Van der Weijden GA, Timmerman MF, Reijerse E, Wolffe GN, Van 
Winkelhoff AJ, Van der Velden U. The prevalence of A. actinomycetemcomitans, P. 
gingivalis and P. intermedia in selected subjects with periodontitis. J Clin Periodontol 
1994;21: 583-8. 
[4] Haraszthy VI, Hariharan G, Tinoco EM, Cortelli JR, Lally ET, Davis E, 
Zambon JJ. Evidence for the role of highly leukotoxic Actinobacillus 
actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of 
early-onset periodontitis. J Periodontol 2000;71: 912-22. 
[5] van Winkelhoff AJ, de Groot P, Abbas F, de Graaff J. Quantitative aspects of 
the subgingival distribution of Actinobacillus actinomycetemcomitans in a patient 
with localized juvenile periodontitis. J Clin Periodontol 1994;21: 199-202. 
[6] van Winkelhoff AJ, Slots J. Actinobacillus actinomycetemcomitans and 
Porphyromonas gingivalis in nonoral infections. Periodontol 2000 1999;20: 122-35. 
[7] Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of 
periodontal pathogens in atheromatous plaques. J Periodontol 2000;71: 1554-60. 
[8] Henderson B, Ward JM, Ready D. Aggregatibacter (Actinobacillus) 
actinomycetemcomitans: a triple A* periodontopathogen? Periodontol 2000 2010;54: 
78-105. 
[9] Fine DH, Kaplan JB, Kachlany SC, Schreiner HC. How we got attached to 
Actinobacillus actinomycetemcomitans: A model for infectious diseases. Periodontol 
2000 2006;42: 114-57. 
[10] Jinadasa RN, Bloom SE, Weiss RS, Duhamel GE. Cytolethal distending toxin: 
a conserved bacterial genotoxin that blocks cell cycle progression, leading to 
apoptosis of a broad range of mammalian cell lineages. Microbiology 2011;157: 
1851-75. 
[11] Belibasakis G, Johansson A, Wang Y, Claesson R, Chen C, Asikainen S, 
Kalfas S. Inhibited proliferation of human periodontal ligament cells and gingival 
fibroblasts by Actinobacillus actinomycetemcomitans: involvement of the cytolethal 
distending toxin. Eur J Oral Sci 2002;110: 366-73. 
[12] Belibasakis GN, Mattsson A, Wang Y, Chen C, Johansson A. Cell cycle arrest 
of human gingival fibroblasts and periodontal ligament cells by Actinobacillus 
actinomycetemcomitans: involvement of the cytolethal distending toxin. Apmis 
2004;112: 674-85. 
[13] Ohara M, Oswald E, Sugai M. Cytolethal distending toxin: a bacterial bullet 
targeted to nucleus. J Biochem 2004;136: 409-13. 
  
16 
16 
[14] Johansson A, Claesson R, Hanstrom L, Kalfas S. Serum-mediated release of 
leukotoxin from the cell surface of the periodontal pathogen Actinobacillus 
actinomycetemcomitans. Eur J Oral Sci 2003;111: 209-15. 
[15] Kato S, Kowashi Y, Demuth DR. Outer membrane-like vesicles secreted by 
Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb Pathog 
2002;32: 1-13. 
[16] Kachlany SC. Aggregatibacter actinomycetemcomitans leukotoxin: from 
threat to therapy. J Dent Res 2010;89: 561-70. 
[17] Kelk P, Johansson A, Claesson R, Hanstrom L, Kalfas S. Caspase 1 
involvement in human monocyte lysis induced by Actinobacillus 
actinomycetemcomitans leukotoxin. Infect Immun 2003;71: 4448-55. 
[18] Lally ET, Hill RB, Kieba IR, Korostoff J. The interaction between RTX toxins 
and target cells. Trends Microbiol 1999;7: 356-61. 
[19] Korostoff J, Yamaguchi N, Miller M, Kieba I, Lally ET. Perturbation of 
mitochondrial structure and function plays a central role in Actinobacillus 
actinomycetemcomitans leukotoxin-induced apoptosis. Microb Pathog 2000;29: 267-
78. 
[20] Kelk P, Claesson R, Hanstrom L, Lerner UH, Kalfas S, Johansson A. 
Abundant secretion of bioactive interleukin-1beta by human macrophages induced by 
Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2005;73: 453-8. 
[21] Kelk P, Claesson R, Chen C, Sjostedt A, Johansson A. IL-1beta secretion 
induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly 
caused by the leukotoxin. Int J Med Microbiol 2008;298: 529-41. 
[22] Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M. Risk of 
aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter 
(Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal 
cohort study. Lancet 2008;371: 237-42. 
[23] Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis 
factor to periodontal tissue destruction. J Periodontol 2003;74: 391-401. 
[24] Delima AJ, Karatzas S, Amar S, Graves DT. Inflammation and tissue loss 
caused by periodontal pathogens is reduced by interleukin-1 antagonists. J Infect Dis 
2002;186: 511-6. 
[25] Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL-1beta profiles in 
periodontal disease. J Clin Periodontol 2002;29: 48-53. 
[26] Bostanci N, Emingil G, Saygan B, Turkoglu O, Atilla G, Curtis MA, 
Belibasakis GN. Expression and regulation of the NALP3 inflammasome complex in 
periodontal diseases. Clin Exp Immunol 2009;157: 415-22. 
[27] Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87: 
2095-147. 
[28] Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura 
MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, et al. A novel heterodimeric 
cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 
1992;356: 768-74. 
[29] Matsushima K, Taguchi M, Kovacs EJ, Young HA, Oppenheim JJ. 
Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity 
and release of biologically active IL 1 from monocytes by trypsin and plasmin. J 
Immunol 1986;136: 2883-91. 
[30] Schroder K, Tschopp J. The inflammasomes. Cell 2010;140: 821-32. 
[31] Ogura Y, Sutterwala FS, Flavell RA. The inflammasome: first line of the 
immune response to cell stress. Cell 2006;126: 659-62. 
  
17 
17 
[32] Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, 
Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, Mocsai A, Tschopp J, 
Ruland J. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal 
host defence. Nature 2009;459: 433-6. 
[33] Ng J, Hirota SA, Gross O, Li Y, Ulke-Lemee A, Potentier MS, Schenck LP, 
Vilaysane A, Seamone ME, Feng H, Armstrong GD, Tschopp J, Macdonald JA, 
Muruve DA, Beck PL. Clostridium difficile toxin-induced inflammation and intestinal 
injury are mediated by the inflammasome. Gastroenterology 2010;139: 542-52, 552 
e1-3. 
[34] Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma 
M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. Cryopyrin activates the 
inflammasome in response to toxins and ATP. Nature 2006;440: 228-32. 
[35] Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, McElvania-
Tekippe E, Ting JP, Duncan JA. Staphylococcus aureus alpha-hemolysin activates the 
NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 2009;4: 
e7446. 
[36] Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, Kastner DL. 
Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to 
endotoxin and a defect in macrophage apoptosis. Mol Cell 2003;11: 591-604. 
[37] Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, Kastner DL. The 
B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly 
with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A 2006;103: 
9982-7. 
[38] Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, Bailly-Maitre B, 
Volkmann N, Hanein D, Rouiller I, Reed JC. Reconstituted NALP1 inflammasome 
reveals two-step mechanism of caspase-1 activation. Mol Cell 2007;25: 713-24. 
[39] Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform 
triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 
2002;10: 417-26. 
[40] Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility 
to anthrax lethal toxin. Nat Genet 2006;38: 240-4. 
[41] Grenier JM, Wang L, Manji GA, Huang WJ, Al-Garawi A, Kelly R, Carlson 
A, Merriam S, Lora JM, Briskin M, DiStefano PS, Bertin J. Functional screening of 
five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB 
and caspase-1. FEBS Lett 2002;530: 73-8. 
[42] Kempster SL, Belteki G, Forhead AJ, Fowden AL, Catalano RD, Lam BY, 
McFarlane I, Charnock-Jones DS, Smith GC. Developmental control of the Nlrp6 
inflammasome and a substrate, IL-18, in mammalian intestine. Am J Physiol 
Gastrointest Liver Physiol 2011;300: G253-63. 
[43] Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, Peyrin-
Biroulet L, Lemoine Y, Hot D, Chamaillard M. Nod-like receptor pyrin domain-
containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal 
carcinogenesis upon injury. Proc Natl Acad Sci U S A 2011;108: 9601-6. 
[44] Chen GY, Liu M, Wang F, Bertin J, Nunez G. A functional role for Nlrp6 in 
intestinal inflammation and tumorigenesis. J Immunol 2011;186: 7187-94. 
[45] Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper 
DR, Bertin J, Eisenbarth SC, Gordon JI, Flavell RA. NLRP6 inflammasome regulates 
colonic microbial ecology and risk for colitis. Cell 2011;145: 745-57. 
[46] van Ooij C. Immunology: NLRP6 keeps the bad bacteria at bay. Nat Rev 
Microbiol 2011;9: 481. 
  
18 
18 
[47] Burckstummer T, Baumann C, Bluml S, Dixit E, Durnberger G, Jahn H, 
Planyavsky M, Bilban M, Colinge J, Bennett KL, Superti-Furga G. An orthogonal 
proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the 
inflammasome. Nat Immunol 2009;10: 266-72. 
[48] Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, 
Caffrey DR, Latz E, Fitzgerald KA. AIM2 recognizes cytosolic dsDNA and forms a 
caspase-1-activating inflammasome with ASC. Nature 2009;458: 514-8. 
[49] Johansson A. Aggregatibacter actinomycetemcomitans Leukotoxin: A 
Powerful Tool with Capacity to Cause Imbalance in the Host Inflammatory Response. 
Toxins 2011;3: 242-259. 
[50] Nalbant A, Chen C, Wang Y, Zadeh HH. Induction of T-cell apoptosis by 
Actinobacillus actinomycetemcomitans mutants with deletion of ltxA and cdtABC 
genes: possible activity of GroEL-like molecule. Oral Microbiol Immunol 2003;18: 
339-49. 
[51] Johansson A, Sandstrom G, Claesson R, Hanstrom L, Kalfas S. Anaerobic 
neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to 
the bacterial leukotoxicity. Eur J Oral Sci 2000;108: 136-46. 
[52] Johansson A, Claesson R, Belibasakis G, Makoveichuk E, Hanstrom L, 
Olivecrona G, Sandstrom G, Kalfas S. Protease inhibitors, the responsible 
components for the serum-dependent enhancement of Actinobacillus 
actinomycetemcomitans leukotoxicity. Eur J Oral Sci 2001;109: 335-41. 
[53] Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for 
metabolic danger? Science 2010;327: 296-300. 
[54] Taxman DJ, Zhang J, Champagne C, Bergstralh DT, Iocca HA, Lich JD, Ting 
JP. Cutting edge: ASC mediates the induction of multiple cytokines by 
Porphyromonas gingivalis via caspase-1-dependent and -independent pathways. J 
Immunol 2006;177: 4252-6. 
[55] Meixenberger K, Pache F, Eitel J, Schmeck B, Hippenstiel S, Slevogt H, 
N'Guessan P, Witzenrath M, Netea MG, Chakraborty T, Suttorp N, Opitz B. Listeria 
monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, 
depending on listeriolysin O and NLRP3. J Immunol 2010;184: 922-30. 
[56] Yilmaz O, Sater AA, Yao L, Koutouzis T, Pettengill M, Ojcius DM. ATP-
dependent activation of an inflammasome in primary gingival epithelial cells infected 
by Porphyromonas gingivalis. Cell Microbiol 2010;12: 188-98. 
[57] Taxman DJ, Huang MT, Ting JP. Inflammasome inhibition as a pathogenic 
stealth mechanism. Cell Host Microbe 2010;8: 7-11. 
[58] Bostanci N, Meier A, Guggenheim B, Belibasakis GN. Regulation of NLRP3 
and AIM2 inflammasome gene expression levels in gingival fibroblasts by oral 
biofilms. Cell Immunol 2011;270: 88-93. 
[59] Kelk P, Abd H, Claesson R, Sandstrom G, Sjostedt A, Johansson A. Cellular 
and molecular response of human macrophages exposed to Aggregatibacter 
actinomycetemcomitans leukotoxin. Cell Death Dis 2011;2: e126. 
 
 
 
Tables 
Table 1 
  
19 
19 
   LDH release (mean ± SEM) PI staining (% of total) 
Control   1.00 ± 0.35          9.77 
D7SS WT   1.01 ± 0.49    14.06 
D7SS DLtxA   0.92 ± 0.14    12.98 
D7SS DCdtABC  0.85 ± 0.16     9.23 
D7SS DLtxACdtABC 0.60 ± 0.57    10.11 
 
LDH release and PI staining in MNLs challenged with A. 
actinomycetemcomitans. MNLs were cultured for 3 h in the presence or absence of 
the A. actinomycetemcomitans D7SS wild-type (WT) or the knock-out mutant strains 
D7SS DLtxA, D7SS DCdtABC, or double mutant D7SS DLtxACdtABC. The released 
LDH was measured colorimetrically and the results are presented as mean absorbance 
± standard error of mean (SEM) from triplicate cultures. The nuclear PI staining was 
measured by flow cytometry and the results are expressed as the percentage of 
positively stained cells in the culture, in a population of 10000 cells in each sample 
(one experiment). 
 
Table 2 
   IL-1β concentration (mean ± SD) 
Control   108.4 ± 28.3 pg/ml 
D7SS WT   200.3 ± 47.5 pg/ml * 
D7SS DLtxA   191.4 ± 12.2 pg/ml * 
D7SS DCdtABC  183.9 ± 9.6 pg/ml * 
D7SS DLtxACdtABC 206.5 ± 25.4 pg/ml * 
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IL-1β secretion by human MNLs in response to A. actinomycetemcomitans. MNLs 
were cultured for 3 h in the presence or absence of the A. actinomycetemcomitans 
D7SS wild-type (WT) or the knock-out mutant strains D7SS DLtxA, D7SS DCdtABC, 
or double mutant D7SS DLtxACdtABC (1:10 cell: bacteria ratio). The secreted IL-1β 
in the culture media was measured by commercially available ELISA. The 
concentrations are measured in pg/ml and the results are presented as mean 
concentrations ± standard deviation (SD) from three independent experiments. The 
asterisk represents statistically significant difference compared to the control group 
(P<0.05). 
 
Figure Legends 
Figure 1 
Analysis of the MNL fraction by FACS. Flow cytometric analysis was used to 
determine the cell populations in the MNL fraction isolated from human blood, by 
combined FSC/SSC measurement. The sub-fraction of lymphocytes comprises 
approximately 70 % of the total MNL population, whereas the sub-fraction of 
monocytes comprises approximately 30 % of the total MNL population. 
Representative results from the MNL isolation process are shown. 
 
Figure 2 
Effect of A. actinomycetemcomitans on the expression of inflammasome sensors in 
MNLs. The various A. actinomycetemcomitans strains were used to challenge 
macropghages at 1:10 cell: bacteria ratio, for 3 h. The gene expression levels of 
NLRP1 (A), NLRP2 (B), AIM2 (C), NLRP3 (D) and NLRP6 (E) were measured by 
qPCR analysis, normalized against the expression levels of the average of GAPDH 
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and UBC (housekeeping genes). The results are expressed as the 2-∆CT formula. Bars 
represent mean values ± SEM from three independent experiments. The asterisk 
represents statistically significant difference compared to the control group (P<0.05). 
Un-challenged control (Con), D7SS wild-type strain (WT), D7SS DLtxA strain 
(DLtx), D7SS DCdtACB strain (DCdt), D7SS DLtxACdtABC strain (DLtxCdt). 
 
Figure 3 
Effect of A. actinomycetemcomitans on ASC and Caspase-1 expression in MNLs. 
The various A. actinomycetemcomitans strains were used to challenge macropghages 
at 1:10 cell: bacteria ratio, for 3 h. The gene expression levels of ASC (A) and 
Caspase-1 (B) were measured by qPCR analysis, normalized against the expression 
levels of the average of GAPDH and UBC (housekeeping genes). The results are 
expressed as the 2-∆CT formula. Bars represent mean values ± SEM from three 
independent experiments. The asterisk represents statistically significant difference 
compared to the control group (P<0.05). Un-challenged control (Con), D7SS wild-
type strain (WT), D7SS DLtxA strain (DLtx), D7SS DCdtACB strain (DCdt), D7SS 
DLtxACdtABC strain (DLtxCdt). 
 
Figure 4 
.Effect of A. actinomycetemcomitans on IL-1β and IL-18 expression in MNLs. The 
various A. actinomycetemcomitans strains were used to challenge macropghages at 
1:10 cell: bacteria ratio, for 3 h. The gene expression levels of IL-1β (A) and IL-18 
(B) were measured by qPCR analysis, normalized against the expression levels of the 
average of GAPDH and UBC (housekeeping genes). The results are expressed as the 
2-∆CT formula. Bars represent mean values ± SEM from three independent 
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experiments. The asterisk represents statistically significant difference compared to 
the control group (P<0.05). Un-challenged control (Con), D7SS wild-type strain 
(WT), D7SS DLtxA strain (DLtx), D7SS DCdtACB strain (DCdt), D7SS 
DLtxACdtABC strain (DLtxCdt). 
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